Renee Gaeta Biography and Net Worth

CFO of Outset Medical

Renee Gaeta joined Outset in June 2025 as Chief Financial Officer. In addition to leading the Outset Finance organization, Renee is responsible for Human Resources and Information Technology.

She most recently served as CFO of Shockwave Medical until its acquisition by Johnson and Johnson in May 2024. She was previously CFO at Eko Health, a private company focused on cardiopulmonary digital health solutions, and Establishment Labs, where she played a key role in the company’s initial public offering and growing the global business. She has served as a member of the board of directors and the audit committee of Candel Therapeutics since August 2022 and was previously audit committee chair and a board director of SeaSpine Holdings from 2019 until its acquisition in 2023 by Orthofix Medical. She received her Bachelor of Science, cum laude, in accounting from Loyola Marymount University and is a Certified Public Accountant in California.

What is Renee Gaeta's net worth?: The estimated net worth of Renee Gaeta is at least $567.84 thousand as of August 17th, 2026. Ms. Gaeta owns 180,840 shares of Outset Medical stock worth more than $567,838 as of September 23rd. This net worth evaluation does not reflect any other assets that Ms. Gaeta may own. Learn More about Renee Gaeta's net worth.
How do I contact Renee Gaeta?: The corporate mailing address for Ms. Gaeta and other Outset Medical executives is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. Outset Medical can also be reached via phone at 669-231-8200 and via email at [email protected]. Learn More on Renee Gaeta's contact information.
Has Renee Gaeta been buying or selling shares of Outset Medical?: During the past quarter, Renee Gaeta has sold $19,943.77 in Outset Medical stock. Most recently, Renee Gaeta sold 4,543 shares of the business's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $4.39, for a transaction totalling $19,943.77. Following the completion of the sale, the chief financial officer now directly owns 180,840 shares of the company's stock, valued at $793,887.60. Learn More on Renee Gaeta's trading history.
Who are Outset Medical's active insiders?: Outset Medical's insider roster includes Nabeel Ahmed (VP), John Brottem (General Counsel), Rebecca Chambers (CFO), Karen Drexler (Director), Renee Gaeta (CFO), D. Grossman (Director), James Hinrichs (Director), Marc Nash (SVP), Leslie Trigg (CEO), Martin Vazquez (COO), and Steven Williamson (Insider). Learn More on Outset Medical's active insiders.
Are insiders buying or selling shares of Outset Medical?: In the last year, insiders at the sold shares 23 times. They sold a total of 79,958 shares worth more than $369,186.67. The most recent insider tranaction occured on August, 17th when General Counsel John L. Brottem sold 2,632 shares worth more than $11,554.48. Insiders at Outset Medical own 2.5% of the company. Learn More about insider trades at Outset Medical.
Information on this page was last updated on 8/17/2026.

Renee Gaeta Insider Trading History at Outset Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/17/2026	Sell	4,543	$4.39	$19,943.77	180,840
6/3/2026	Sell	17,672	$4.94	$87,299.68	113,753

Renee Gaeta Buying and Selling Activity at Outset Medical

Outset Medical Company Overview

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Today's Range

Now: $3.11

$3.12

$3.25

50 Day Range

MA: $4.09

$3.10

$5.22

2 Week Range

Now: $3.11

$3.00

$16.16

Volume

54,012 shs

Average Volume

368,613 shs

Market Capitalization

$58.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.9